UPMC Cancer Center at UPMC Northwest — Seneca, Pennsylvania

Public research footprint of UPMC Cancer Center at UPMC Northwest, compiled from the ClinicalTrials.gov public registry.

117

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma · Lung Non-Small Cell Carcinoma · Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Recurrent Neck Squamous Cell Carcinoma of Unknown Primary

Recently updated registry entries

NCT06203600 — Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)
NCT03419234 — Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UPMC Cancer Center at UPMC Northwest?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.